Limited Proteolysis of Cyclooxygenase-2 Enhances Cell Proliferation

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• Cyclooxygenase-2 (COX-2) is increasingly recognized for functions beyond prostaglandin synthesis.
• Evidence suggests COX-2 may have catalytic-independent roles in cellular processes.
• Tumorigenesis involves complex molecular alterations, including protein modifications.

Purpose of the Study:

• To investigate the role of COX-2 proteolysis in cancer cell proliferation.
• To identify the mechanisms by which COX-2 cleavage products influence cell growth.
• To explore the non-catalytic functions of COX-2 fragments in nuclear compartments.

Main Methods:

• Point mutations were introduced into COX-2 to study proteolysis and its effects.
• Immunohistochemistry and Western blotting were used to detect COX-2 fragments.
• Transcriptomic and proteomic analyses were performed to identify associated molecular pathways.
• Interaction studies with beta-catenin were conducted.

Main Results:

• A K598R mutation in COX-2 led to nuclear fragment formation and enhanced cell proliferation.
• Additional mutations preventing fragment formation abolished the proliferation increase.
• K598R COX-2 altered the expression of genes involved in RNA metabolism.
• A catalytically inactive COX-2 fragment (ΔNT-COX-2) also increased proliferation and interacted with β-catenin.

Conclusions:

• COX-2 cleavage products can promote cell proliferation through mechanisms independent of prostaglandin synthesis.
• Nuclear COX-2 fragments may regulate RNA metabolism and interact with key transcription factors like β-catenin.
• These findings reveal novel, non-catalytic roles for COX-2 in cancer progression.